Dopamine Receptors in the Gastrointestinal Tract

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Dopamine in the Gut

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-981-33-6586-5_3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Source of dopamine in gastric juice and luminal dopamine‐induced duodenal bicarbonate secretion via apical dopamine D2 receptors

  2020cited by this paper
• Opposite effects of dopamine on the mechanical activity of circular and longitudinal muscle of human colon

  2020cited by this paper
• Dopamine Uses the DRD5-ARRB2-PP2A Signaling Axis to Block the TRAF6-Mediated NF-κB Pathway and Suppress Systemic Inflammation.

  2020cited by this paper
• Stomach Gastrin is Regulated by Sodium via PPAR-α and Dopamine D1 Receptor.

  2019cited by this paper
• Dopamine promotes colonic mucus secretion through dopamine D5 receptor in rats.

  2019cited by this paper
• Dopamine and Serotonin Receptors Cooperatively Modulate Pacemaker Activity of Intestinal Cells of Cajal.

  2018cited by this paper
• Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery

  2018cited by this paper
• Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine

  2018cited by this paper
• Dopamine receptor D2 is correlated with gastric cancer prognosis

  2017cited by this paper
• Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death

  2017cited by this paper
• Dopamine enhances duodenal epithelial permeability via the dopamine D5 receptor in rodent

  2017cited by this paper
• Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.

  2016cited by this paper
• Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway.

  2016cited by this paper
• Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors

  2016cited by this paper
• Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice

  2016cited by this paper
• Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.

  2015cited by this paper
• De Novo Expression of Dopamine D2 Receptors on Microglia after Stroke

  2015cited by this paper
• Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis

  2015cited by this paper
• Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease

  2015cited by this paper
• Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats.

  2015cited by this paper
• The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6‐hydroxydopamine microinjection in the substantia nigra

  2014cited by this paper
• Dopamine Mediates the Vagal Modulation of the Immune System by Electroacupuncture

  2014cited by this paper
• Dopamine D1 receptors mediate dopamine-induced duodenal epithelial ion transport in rats.

  2013cited by this paper
• Expression of dopamine receptors in human lower esophageal sphincter

  2012cited by this paper
• Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse

  2012cited by this paper
• Cellular localization of dopamine receptors in the gastric mucosa of rats.

  2012cited by this paper
• Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility.

  2012cited by this paper
• Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin

  2012cited by this paper
• D1 receptors play a major role in the dopamine modulation of mouse ileum contractility.

  2010cited by this paper
• Differential response of A 68930 and sulpiride in stress-induced gastric ulcers in rats.

  2010cited by this paper
• The possible involvement of dopamine D3 receptors in the regulation of gastric emptying in rats.

  2010cited by this paper
• Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.

  2010cited by this paper
• Distribution of catechol‐O‐methyltransferase (COMT) proteins and enzymatic activities in wild‐type and soluble COMT deficient mice

  2010cited by this paper
• Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut mu(1)-receptor coupled to 5-HT(1A), D(2), and GABA(B) systems.

  2010cited by this paper
• Dopamine induces contraction in the proximal, but relaxation in the distal rat isolated small intestine.

  2009cited by this paper
• Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis.

  2008cited by this paper
• Effect of Itopride Hydrochloride on the Ileal and Colonic Motility in Guinea Pig In Vitro

  2008cited by this paper
• The D2/D3 Agonist PD128907 (R-(+)-trans-3,4a,10b-Tetrahydro-4-Propyl-2H,5H-[1]Benzopyrano[4,3-b]-1,4-Oxazin-9-ol) Inhibits Stimulated Pyloric Relaxation and Spontaneous Gastric Emptying

  2008cited by this paper
• PERIPHERAL DOPAMINE D2‐LIKE RECEPTORS HAVE A REGULATORY EFFECT ON CARBACHOL‐, HISTAMINE‐ AND PENTAGASTRIN‐STIMULATED GASTRIC ACID SECRETION

  2008cited by this paper
• D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells.

  2006cited by this paper
• DRD2/DARPP-32 Expression Correlates with Lymph Node Metastasis and Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma

  2006cited by this paper
• Dopamine D2 Receptor Polymorphisms in Inflammatory Bowel Disease and the Refractory Response to Treatment

  2006cited by this paper
• Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice

  2006cited by this paper
• Polymorphisms of the Dopamine Receptor Gene DRD2 and Colorectal Cancer Risk

  2005cited by this paper
• Dopamine and noradrenaline control distinct functions in rodent microglial cells.

  2005cited by this paper
• Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptake.

  2004cited by this paper
• Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study.

  2002cited by this paper
• Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.

  2002cited by this paper
• Effects of dopaminergic drugs on inflammatory bowel disease induced with 2,4-dinitrofluorbenzene in BALB/c mice.

  2001cited by this paper
• Identification and regional distribution of the dopamine D(1A) receptor in the gastrointestinal tract.

  2000cited by this paper
• Mice lacking the dopamine transporter display altered regulation of distal colonic motility.

  2000cited by this paper
• Impaired synthesis or cellular storage of norepinephrine, dopamine and 5-hydroxytryptamine in inflammatory bowel disease

  2000cited by this paper
• Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor-independent mechanism.

  1999cited by this paper
• Characterization of Dopamine Receptor Subtypes Involved in Experimentally Induced Gastric and Duodenal Ulcers in Rats

  1999cited by this paper
• Decreased Dopamine Receptor Expression and Its Second-Messenger cAMP in Malignant Human Colon Tissue

  1999cited by this paper
• Dopamine Produced by the Stomach May Act as a Paracrine/ Autocrine Hormone in the Rat

  1998cited by this paper
• Alteration of Dopamine D2 Receptors in Human Malignant Stomach Tissue

  1997cited by this paper
• Gastric and Duodenal Anti‐ulcer Activity of SKF 38393, a Dopamine D1‐Receptor Agonist in Rats

  1995cited by this paper
• Stimulatory effect of dopamine on acid secretion from the isolated rat stomach.

  1995cited by this paper
• Central and peripheral dopamine D1/DA1 receptor modulation of gastric secretion and experimental gastric mucosal injury.

  1995cited by this paper
• Inhibitory effect of dopamine on gastric motility in rats.

  1995cited by this paper
• A differential dopamine receptor involvement during stress ulcer formation in rats.

  1994cited by this paper
• Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat.

  1994cited by this paper
• Role of dopamine and other stimuli of mucosal bicarbonate secretion in duodenal protection

  1994cited by this paper
• A dopamine D3 receptor agonist, 7-hydroxy-N,N-di-n-propyl-2-aminotetralin, reduces gastric acid and pepsin secretion and experimental gastric mucosal injury in rats.

  1994cited by this paper
• Gastric and duodenal anti-ulcer activity of sulpiride, a dopamine D2 receptor antagonist, in rats

  1994cited by this paper
• Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds.

  1993cited by this paper
• Identification of dopamine1A receptors in the rat small intestine.

  1993cited by this paper
• Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.

  1992cited by this paper
• The effect of dopamine on rat gastric motility

  1992cited by this paper
• Characterization of receptors mediating the effects of dopamine on gastric smooth muscle

  1991cited by this paper
• Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.

  1990cited by this paper
• Increased dopamine receptor binding in duodenal mucosa of duodenal ulcer patients

  1989cited by this paper
• Octopamine relaxes rabbit jejunal smooth muscle by selective activation of dopamine D1 receptors

  1988cited by this paper
• Dopamine receptors in human gastrointestinal mucosa.

  1987cited by this paper
• DA1 receptor mediates dopamine-induced relaxation of opossum lower esophageal sphincter in vitro.

  1986cited by this paper
• Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.

  1980cited by this paper

• Oral administration of aripiprazole to Drosophila causes intestinal toxicity

  2025cites this paper
• Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease

  2024cites this paper
• Dopamine in the regulation of glucose and lipid metabolism: a narrative review

  2024cites this paper
• Intestinal epithelial dopamine receptor signaling drives sex-specific disease exacerbation in a mouse model of multiple sclerosis.

  2023cites this paper
• Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration

  2022cites this paper
• Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats

  2022cites this paper
• Effects of Psychotropic Medication on Somatic Sterol Biosynthesis of Adult Mice

  2022cites this paper